SYM Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
SYM Financial's REGN Position: Q3 2026 in Review
SYM Financial increased its Regeneron Pharmaceuticals (REGN) stake by 25% in Q3 2026, buying an estimated $109K and bringing the position to 718 shares worth $544K. The position accounts for 0.04% of the portfolio, ranked #152.
SYM Financial first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- SYM Financial held 718 shares of Regeneron Pharmaceuticals worth $544K as of Q3 2026.
- SYM Financial bought 144 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $109K.
- Regeneron Pharmaceuticals made up 0.04% of SYM Financial's portfolio in Q3 2026, its #152 holding.
- SYM Financial first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.